Recall of Oxoid Legionella Pneumophila Serogroup 2-14 Test

According to New Zealand Medicines and Medical Devices Safety Authority, this recall involved a device in New Zealand that was produced by manufacturer #1479.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    16895
  • Event Initiated Date
    2014-06-27
  • Event Country
  • Event Source
    NZMMDSA
  • Event Source URL
  • Notes / Alerts
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
  • Extra notes in the data
    Recalling Organisation: Oxoid NZ, 3 Atlas Place, Mairangi Bay, AUCKLAND 1333
  • Reason
    A technical investigation has confirmed that there is potential for a weak or negative reaction when using oxoid legionella pneumophila 2-14 reagent lot:1301912 with serogroup 9 isolates. this reagent is contained within the kits noted above. continued use of this reagent may result in a delay to the correct characterisation of l.Pneumophila serogroup 9 isolates.
  • Action
    Product to be destroyed

Device

Manufacturer